Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

HE-2100 protects nonhuman primates from effects of radiation exposure

April 9, 2003

Enrollment complete in phase III trial of Vivitrex in alcohol dependence

April 3, 2003

Large Scale Biology and U. of Arkansas enter agreement for drug intervention therapy

March 5, 2003

5-HT1A agonists with utility in the treatment of opioid dependence

March 5, 2003

Potential use of selegiline hydrochloride in promoting smoking cessation

March 4, 2003

NicVAX phase I/II trial begins enrollment

Feb. 21, 2003

U. of Michigan claims dopamine receptor modulators for cocaine abuse and other disorders

Jan. 29, 2003

Xenova buys out ImmuLogic's interests in TA-CD and TA-NIC programs

Jan. 17, 2003

AME-359 protects rats from cocaine overdose

Jan. 14, 2003

CeNeS outlicenses CEE-03-310 to Swiss biopharmaceutical company

Jan. 3, 2003

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...